### Evidence Statement CG15AdultES90
In 1989, the European NIDDM Policy Group (Type 2 diabetes) suggested HbA 1 was good <8.5%, acceptable 8.59.5%, poor >9.5% (equivalent to HbA 1c of <6.9, 6.97.7, >7.7%). No ev idence for these limits was given, and it was not clear whether the intent was for micro- or macrovascular protection or both. However, the need to individualise by life expectancy was acknowledged 114



[@Alberti_1988]
